HCA — HCA Healthcare Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedLarge CapSuper Stock
- $67.58bn
- $106.88bn
- $58.75bn
- 92
- 62
- 90
- 94
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.19 | ||
| PEG Ratio (f) | 2.22 | ||
| EPS Growth (f) | 6.32% | ||
| Dividend Yield (f) | 1.09% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 16.19 | ||
| Price to Sales | 1.13 | ||
| EV to EBITDA | 8.99 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.46% | ||
| Return on Equity | n/a | ||
| Operating Margin | 14.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 43,614 | 46,677 | 51,336 | 51,533 | 58,752 | 60,369.08 | 62,760.07 | 7.21% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -0.05 | +21.11 | +27.17 | +10.78 | +48.84 | -1.72 | +7 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HCA Healthcare, Inc. is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. It owns and operates approximately 182 hospitals, comprised of 175 general, acute care hospitals; five psychiatric hospitals; and two rehabilitation hospitals. The Company also operates around 125 freestanding surgery centers and over 21 freestanding endoscopy centers. The Company operates in two geographically organized groups: The National and American Groups. The National Group includes 96 hospitals located in Alaska, California, Florida, Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, North Carolina, South Carolina, Utah and Virginia. The American Group includes approximately 79 hospitals located in Colorado, Kansas, southern Kentucky, Louisiana, Missouri, Tennessee and Texas. The Company also operates seven hospitals in England. Its facilities are located in over 20 states and England.
Directors
- Thomas Frist CHM (53)
- Samuel Hazen CEO (60)
- William Rutherford CFO (57)
- Jon Foster CEX (59)
- Charles Hall CEX (67)
- Arnold Moore CEX (60)
- Jennifer Berres CHO (50)
- Michael Cuffe EVP (55)
- J. William Morrow SVF (51)
- Paul Paslick SVP (61)
- Kathleen Whalen SVP (57)
- Robert Waterman SVP (67)
- Christopher Wyatt SVP (43)
- Deborah Reiner SVP (59)
- Phillip Billington SVP (53)
- Jeff Cohen SVP (49)
- Jane Englebright SVP (63)
- Michael McAlevey SVP
- Sandra Morgan SVP (58)
- Joseph Sowell SVP (64)
- Kathryn Torres SVP (57)
- William Frist DRC (51)
- Meg Crofton IND (67)
- Robert Dennis IND (67)
- Nancy-ann Deparle IND (64)
- Charles Holliday IND (73)
- Hugh Johnston IND (60)
- Michael Michelson IND (69)
- Wayne Riley IND (61)
- Andrea Smith IND (54)
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- October 19th, 2010
- Public Since
- March 10th, 2011
- No. of Shareholders
- 400
- No. of Employees
- 204,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 282,716,700
- Address
- 1 Park Plz, NASHVILLE, 37203-6527
- Web
- https://hcahealthcare.com/
- Phone
- +1 6153449551
- Auditors
- Ernst & Young LLP
Upcoming Events for HCA
Dividend For HCA.N - 0.5600 USD
Q4 2022 HCA Healthcare Inc Earnings Release
Q1 2023 HCA Healthcare Inc Earnings Release
HCA Healthcare Inc Annual Shareholders Meeting
Similar to HCA
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners LLC
New York Stock Exchange
Ati Physical Therapy
New York Stock Exchange
FAQ
What is the HCA Healthcare share price?
As of Today at 18:09 UTC, shares in HCA Healthcare are trading at $239.03. This share price information is delayed by 15 minutes.
How has the HCA Healthcare share price performed this year?
Shares in HCA Healthcare last closed at $239.03 and the price had moved by +3% over the past 365 days. In terms of relative price strength the HCA Healthcare share price has outperformed the S&P500 Index by +14.81% over the past year.
What are the analyst and broker recommendations for HCA Healthcare?
The overall consensus recommendation for HCA Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the HCA Healthcare dividend yield?
The HCA Healthcare dividend yield is 0.9% based on the trailing twelve month period.
Does HCA Healthcare pay a dividend?
Last year, HCA Healthcare paid a total dividend of $2.16, and it currently has a trailing dividend yield of 0.9%.Looking ahead, shares in HCA Healthcare are due to go ex-dividend on 2022-12-13 and the next dividend pay date is 2022-12-28.
When does HCA Healthcare next pay dividends?
HCA Healthcare are due to go ex-dividend on 2022-12-13 and the next dividend pay date is 2022-12-28. The historic dividend yield on HCA Healthcare shares is currently 0.9%.
How do I buy HCA Healthcare shares?
To buy shares in HCA Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HCA Healthcare?
As of the previous close price of $239.03, shares in HCA Healthcare had a market capitalisation of $67.58bn.
Where are HCA Healthcare shares listed?
Here are the trading details for HCA Healthcare:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: HCA
What kind of share is HCA Healthcare?
Based on an overall assessment of its quality, value and momentum HCA Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HCA Healthcare share price forecast for 2022?
The analyst consensus target price for shares in HCA Healthcare is $242.86. That is 1.6% above the last closing price of $239.03.
Analysts covering HCA Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $17.02 for the next financial year.
What is the trend in the HCA Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HCA Healthcare. Over the past six months, its share price has outperformed the S&P500 Index by +16.55%.
As of the last closing price of $239.03, shares in HCA Healthcare were trading +10.23% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HCA Healthcare PE Ratio?
The HCA Healthcare PE ratio based on its reported earnings over the past 12 months is 13.19. The shares last closed at $239.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HCA Healthcare?
HCA Healthcare's management team is headed by:
- Thomas Frist - CHM
- Samuel Hazen - CEO
- William Rutherford - CFO
- Jon Foster - CEX
- Charles Hall - CEX
- Arnold Moore - CEX
- Jennifer Berres - CHO
- Michael Cuffe - EVP
- J. William Morrow - SVF
- Paul Paslick - SVP
- Kathleen Whalen - SVP
- Robert Waterman - SVP
- Christopher Wyatt - SVP
- Deborah Reiner - SVP
- Phillip Billington - SVP
- Jeff Cohen - SVP
- Jane Englebright - SVP
- Michael McAlevey - SVP
- Sandra Morgan - SVP
- Joseph Sowell - SVP
- Kathryn Torres - SVP
- William Frist - DRC
- Meg Crofton - IND
- Robert Dennis - IND
- Nancy-ann Deparle - IND
- Charles Holliday - IND
- Hugh Johnston - IND
- Michael Michelson - IND
- Wayne Riley - IND
- Andrea Smith - IND